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Abstract 
Aims: The Unified Protocol (UP) is indicated when patients present with comorbidity, but no 
studies have investigated the effectiveness of the UP with comorbid health anxiety and 
depression. Method: An A/B single case design evaluated outcomes for a 27-year-old male 
presenting with health anxiety and comorbid depression. Following a 21-day assessment-
baseline period, the manualised UP was delivered across  a 42-day period containing seven 
intervention sessions.  Four idiographic measures (occurrence and duration of health 
checking, sleep duration and food intake satisfaction) were collected daily throughout and 
two nomothetic measures were collected at four time-points.  Results: All sessions were 
attended.  Number of health checking episodes reduced from four per day to two per day.  A 
59 minute per day reduction in time spent health checking occurred and sleep increased by 
100-minutes per night.  There was little apparent change in terms of food intake satisfaction. 
There was a reliable and clinically significant reduction in depression. Discussion:  Further 
testing of the effectiveness of the UP with comorbid health anxiety and depression in a true 
single case experimental design is now indicated.  
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Introduction 
Patients that present with comorbidity of anxiety and depression in routine practice 
present the cognitive behavioural therapist with a treatment selection dilemma (Barlow et al., 
2004). One possible approach is to use a disorder specific cognitive behavioural therapy 
(CBT) treatment protocol, whilst monitoring concurrent improvements across other 
comorbidities. Another approach is to deliver one protocol, evaluate outcome, and then begin 
another protocol. Criticisms of the staged approach is that is time consuming, creates 
potential confusion for the patient and requires the therapist to be ‘pan-protocol competent’ 
(see McManus et al., 2010 for a review). An alternative approach is to take a more 
parsimonious approach and deliver a transdiagnostic treatment protocol (Wilamowska et al., 
2010).  Indeed, two meta-analyses have demonstrated the efficacy of transdiagnostic CBT in 
treating anxiety and depression (Andersen et al., 2016; McEvoy et al., 2009).  
The unified protocol (UP; Barlow et al., 2010) is a transdiagnostic and manualised 
form of CBT developed for the treatment of comorbid anxiety and mood disorders. The UP 
targets the shared mechanisms of depression and anxiety (Hirschfeld, 2001) using a short-
term, focused, structured and manualised treatment approach.  Farchione et al., (2012) 
compared 18-sessions of the UP with a waitlist control to show that the UP facilitated 
significant differential improvement in severity, affect and symptom interference.  Barlow et 
al., (2017) found that 16-sessions of the UP was as effective as single-disorder protocols, but 
had lower rates of treatment attrition. Both of these clinical trials however had very limited 
representation of health anxiety as either the principal or comorbid disorder. This lack of 
evidence for the effectiveness of the UP in treating health anxiety as a primary concern has 
been attributed to overlap of health anxiety symptomology with OCD and panic disorder, 
leading to potential misclassification (Olatunji et al., 2014).  One pilot randomised control 
trial set in Iran (Mohammadpour et al., 2018) has also investigated the effectiveness of 
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pharmacotherapy with and without the addition of 12-sessions of the UP for patients with a 
primary diagnosis of generalised anxiety disorder (GAD). Patients showed a significant 
reduction in a variety of outcomes, including health anxiety, but it is not currently clear the 
degree to which findings would generalise to routine care settings in other countries.  
Collectively, these findings provide limited support for the UP in treating health 
anxiety where it is the principal or comorbid disorder. Strong support has been shown for 
single-disorder protocol CBT in the treatment of health anxiety (see Olatunji et al., 2014 for a 
meta-analysis).  So, initial practice-based evidence is required to determine if the UP is 
effective for patients presenting with health anxiety as a primary concern to support the 
rationale for any future randomised clinical trials (RCT) of the UP for health anxiety.  An 
efficient way of generating such practice-based effectiveness evidence is via single case 
methods.  The single case experimental design (SCED) method is based on the establishment 
of a baseline, and thereafter treatment is introduced and/or removed (sometimes randomly) 
according to the specified methodology (Morley, 2017).  A wide range of SCED 
methodologies are possible to evaluate the effectiveness of CBT in routine practice, including 
alternating treatment designs (e.g. Kellett et al., 2020) and multiple-baseline designs (e.g. 
Sauer-Zavala et al., 2017).  
Where only a basic bi-phasic A/B single case design is implemented, then this not a 
SCED but rather an empirical case-study, as no aspect or component of the intervention is 
experimentally controlled (Shadish & Sullivan, 2011).  A bi-phasic design is still nevertheless 
advantageous in the accrual of initial practice-based evidence because such designs are easy 
to implement, create few ethical dilemmas and usefully integrate idiographic and nomothetic 
outcome measurement (McMillan & Morley, 2010). Arco (2015) for example used an 
empirical case study design to assess the effectiveness of CBT and pharmacotherapy for 
OCD and comorbid depression. More recently a number of empirical case studies and SCEDs 
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evaluating UP effectiveness have been completed (Boswell et al., 2014; Hague et al., 2015; 
Sauer-Zavala et al., 2017). Hague et al (2015) for example, used an A/B bi-phasic design to 
evaluate the effectiveness of 8-sessions of the UP with an older adult experiencing co-morbid 
anxiety and depression.  
This study used an A/B empirical case study to evaluate the clinical effectiveness of 
the UP in a case of health anxiety and co-morbid depression in a working age adult. The 
study had three aims. Firstly, to understand the feasibility of delivering brief UP in routine 
practice in terms of treatment engagement and attendance. Secondly, to test whether the UP 
was effective in treating target idiographic measures (i.e., reduce the cumulative time spent 
health checking, reduce number of health checking episodes, create a more stable sleep 
pattern, and greater satisfaction with food intake). Thirdly, to assess reliable and clinically 
significant change on the nomothetic measures of checking behaviour, depression and general 
psychological distress.  
Method 
Participant and Setting   
Consent was sought from the patient to complete and report the study. The UP was 
delivered by a trainee clinical psychologist working under the close supervision of a BABCP 
accredited principle clinical psychologist.  The male patient (‘James’; name changed to 
protect anonymity) was 27-years old. He was referred to a community team in a secondary 
care mental health service from his General Practitioner.  Throughout the study, the patient 
was prescribed Fluoxetine for depression and Buspirone for anxiety. The patient had a long 
history of anxiety and depression, including a hospital admission for attempted suicide (9-
years previously) and regular periods of crisis contact with mental health services. Since 
leaving school, due to his poor mental health, he had only been able to sustain brief periods 
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of employment. James would rarely leave the house (i.e. due to low mood/motivation and 
fear of embarrassment about people judging his checking behaviours). Onset of health 
checking occurred when he was 13-years of age.  The most frequent form of checking was 
for potential throat cancer, which deterred eating, and also created a poor sleep cycle through 
constant health checking at night. James stated that his mood was typically depressed, and 
that the onset of his depression was 15-years of age.  His primary concern was being 
chronically fearful about his physical health status as he frequently believed that he had some 
form of undiagnosed serious illness, typically cancer. His uncle had died of cancer when he 
was an adolescent, triggering for James a psychological focus on his health.  James reported 
occasional health-related panic attacks and frequent reassurance seeking behaviour towards 
his mum and GP.  He had previously received formal diagnoses of OCD, depression, panic 
disorder, health anxiety and dependent personality traits.  James had 16-sessions of CBT 2-
years previously for GAD in the Improving Access to Psychological Therapies (IAPT) 
service using the Dugas treatment protocol for GAD (Dugas et al., 1998) which had been 
unsuccessful.  
Idiographic Measures; Description, Timing and Analysis   
Four idiographic measures were co-developed with James: cumulative time spent 
health checking (recorded as time elapsed in minutes), number of daily health checking 
episodes (count of checking episodes lasting longer than 30 seconds), sleep duration the 
previous night (recoded in hours and minutes) and food intake satisfaction (5-point Likert 
scale from ‘most satisfied’ to ‘least satisfied’). James was encouraged to record checking 
behaviour live during the day and following each checking episode. Eating satisfaction was 
recorded at the end of each day and sleep duration was recorded the following morning. 
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Baseline phases were assessed for stability through visual analysis (time-series plots 
with ordinary least squares regression lines) and statistical analysis (Kendall’s τ).  Should any 
idiographic measure demonstrate statistically significant baseline trend then adjustments 
would be made using τU (Parker et al., 2011). Three tests of non-overlap were employed to 
assess intervention effectiveness. Percentage of data exceeding the median (PEM) refers to 
the percentage of intervention phase data that exceeds the median of the baseline phase. 
Nonoverlap of all pairs (NAP; Parker & Vannest, 2009) makes use of all data, comparing 
every baseline point to every intervention point. Percentage of all nonoverlapping data 
(PAND) is the smallest percentage of data points that would need to be removed to ensure no 
overlap between phases. The Scruggs and Mastropiere (1998) criteria for categorising 
nonoverlap effect sizes were used (50-69% = ‘questionable effectiveness’, 70-89% = 
‘moderate effectiveness’, 90%+ = ‘highly effective’). To assess variability of idiographic 
measures, visual analysis of scatterplots and changes in the standard deviation (SDs) between 
phases were considered. Differences in phase level was assessed using τA-B for which the p-
value equates to that produced by a Mann-Whitney test (Parker et al., 2011).  
Nomothetic Measures; Description, Timing and Analysis   
Nomothetic measures were collected at four time points; (1) baseline start, (2) 
intervention start, (2) mid-intervention and (4) intervention end.  The two valid and reliable 
nomothetic measures used were the CORE-10 (Barkham et al., 2013) and the Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS; Goodman et al., 1989).  The CORE-10 is a ten-item 
measure of global psychological distress selected because of the need to evaluate the impact 
of the CBT on the general psychological well-being of the patient.  The Y-BOCS is a ten-
item measure of checking behaviour and intrusions. The Y-BOCS was selected because the 
patient experienced anxiety-provoking intrusions about his health and engaged in health 
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checking compulsive behaviours. To assess change on these measures, reliable and clinically 
significant change indices (RCSI) were used (Jacobson & Truax, 1991). To achieve RCSI 
there would be reductions in Y-BOCS and CORE-10 scores (from intervention-start to 
intervention-end) that both (a) meet the reliable change index (RCI) and (b) shift into the 
non-clinical range. The CORE-10 has a RCI of 6 and clinical cut-offs of 13 for depression 
and 11 for general psychological distress. The Y-BOCS has a clinical cut-off of 13 and an 
RCI of 5. 
Design  
An A/B design comprising a 21-day baseline phase and 42-day intervention phase. 
The idiographic measures were therefore collected on a daily basis across the two phases, 
totalling an N = 63-day study timeline.  
Baseline Procedure 
Table 1 details the content of the assessment and treatment sessions. The baseline 
phase contained three assessment sessions (sessions 1-3). The initial assessment appointment 
allowed for setting up of the diary (idiographic measures). Idiographic measures were 
collaboratively designed to reflect the main concerns of the patient and which he brought to 
each session for review.  The UP formulation was built collaboratively towards the end of the 
third and final assessment appointment.  Intervention strategies were not employed until the 
first treatment session (session four). The formulation included the main schematic features 
of the UP (Barlow et al., 2017). In response to arising symptoms of health anxiety and 
comorbid depression, James would employ a range of emotionally-driven behaviours (i.e. 
persistent checking, reassurance seeking, withdrawal and rumination). These behaviours 
would frequently lead to undesired consequences (i.e. reduced energy, poor sleep cycle, 
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isolation and dependency), thus perpetuating distress. The aim of the UP was to provide 
James with alternative, flexible and more adaptive means of responding to his emotional 
distress.  
Intervention Procedure  
The UP was employed across seven treatment sessions (i.e., sessions 4-10) with the 
eight modules being covered sequentially in the treatment phase. The first two modules were 
combined during the first treatment session, whilst remaining modules received one session 
each. The contract of therapist input was 10-sessions (including assessment) due to the time 
limits of the clinical placement.  The rationale for delivering the UP protocol was because the 
patient’s treatment in IAPT (i.e. using a disorder specific approach) had been unsuccessful.  
Therefore, an alternative, transdiagnostic approach was selected. A cognitive-behavioural 
approach was still considered appropriate, based on the concerns of the patient and also 
awareness of the UP evidence base.  Sessions lasted for 50-minutes and were delivered in an 
out-patient community clinic.  Homework was agreed at the termination of each session and 
reviewed at the subsequent session.     
Results 
All sessions were attended and homework was consistently completed, demonstrating 
treatment acceptability. Figure 1 contains time-series plots for the four idiographic measures 
with fitted baseline median and ordinary least squares trend lines. There was limited baseline 
trend shown visually through OLS trend lines. This was confirmed by statistical analysis 
(Kendall’s τ, Table 2) as there was no significant baseline trend for any of the idiographic 
measure baseline phases. Baseline trend adjustment was therefore not indicated for other 
analyses. 
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For checking episodes, a highly variable baseline was shown (M = 4.00, SD = 2.59). 
During the treatment phase there was a reduction shown in both level (to M = 1.67) and 
variability (SD 1.24). Similar findings were shown for the checking time measure. That is, 
there was a highly variable baseline phase (M = 83.10, SD = 102.65 [minutes]) followed by 
reductions in level (to M = 24.24) and variability (to SD = 31.70). For both of these 
measures, significant differences between phases were shown using τA-B. Practically, a 
significant reduction was shown in the number of minutes spent health checking each day 
(i.e., 59-minute reduction). There was also a significant reduction in the number of checking 
episodes per day (i.e. four during baseline, two during treatment). The nonoverlap effect-sizes 
(Table 2) for checking measures showed a moderate to highly effective intervention. 
For sleep, there was a highly variable baseline phase (M = 7.71, SD 3.98). An 
increase in level (M = 9.24) was shown during the intervention phase, but this was not 
significant. Nonoverlap results indicated questionable to moderate effect-sizes for increases 
in sleep duration due to intervention. Changes in sleep stability showed marked improvement 
(to SD = 2.09). For food intake (satisfaction with) there was a minor increase in mean from 
the baseline phase (M = 3.38) to the intervention phase (M = 3.62) although not significant. 
This was accompanied by only questionable effect-sizes.   
Table 3 reports the nomothetic outcomes. The CORE-10 shifted from ‘moderate 
distress’ to ‘low distress’ and met RCSI for depression and general psychological distress. 
The Y-BOCS had a 9-point reduction from ‘severe’ to ‘mild’ but remained two points above 
the clinical cut-off at end of treatment. 
 
Discussion 
This study was the first single case approach to investigate the effectiveness of 
abbreviated UP treatment for comorbid health anxiety and depression in a working age adult.  
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Improvements were shown for time spent checking per day and number of daily checking 
episodes. Such improvements are noticeable given the limited time in treatment (i.e., 7 
treatment sessions).  Improvements were less evident for satisfaction with food intake, 
although this may have been hindered by the relatively less severe baseline phase.  Sleep was 
more stable according to changes in standard deviations; however, there was not a significant 
increase in sleep duration.  Reliable and clinically significant change was shown for general 
psychological distress and depression.  Improvement was also shown for checking symptoms 
(Y-BOCS), but this only constituted reliable change.  With regards to how the effects of the 
intervention were generalised, the patient reported engaging in more regular social activity 
with his friends and family and that he had started to investigate attending University courses.  
These results combined support the partial effectiveness of abbreviated UP when treating 
health anxiety and depression. These findings also provide further support for the UP in 
delivering changes on idiographic outcomes. A strength of this study was the utilisation of 
the non-parametric statistics to supplement visual analysis (Chen et al., 2016) and the absence 
of statistically significant trend in the baseline period.  
All sessions were attended, and homework completion was consistent. This provides 
additional support to the emerging evidence base for the acceptability of individualised 
transdiagnostic approaches (Sauer-Zavala et al., 2016; Sauer-Zavala et al., 2017). The module 
selection and ordering in this study was not personalised to the patient or presenting problem. 
Modules were delivered in relatively equal amounts. Future SCEDs should attempt to test the 
effectiveness of idiosyncratic UP formulations and the tailoring of module ordering and 
dosage.  This is because support has previously been shown for individualising UP module 
ordering (Sauer-Zavala et al., 2017). For example, in the current case, more time being 
devoted to the mechanisms thought to underpin health anxiety (e.g., the role of interoceptive 
conditioning) may have led to greater improvements. Future investigation of dose-response 
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relationship in the UP for health anxiety is also required.  This is because disorder-specific 
CBT protocols recommend longer treatment phases (e.g. Salkovskis & Kirk, 1989) and also 
in light of the apparent dose-response relationship for CBT and health anxiety improvements 
(Olatunji et al., 2014).  
The justification for just 10 sessions of input was purely based on the time limitations 
of the clinical placement and so it is acknowledged that this treatment was shorter than 
required for full UP treatment (16 sessions, Barlow et al., 2017).  This shorter course of 
treatment may have curtailed the effectiveness of the intervention.  Despite the limited 
number of sessions, gains were made, particularly with regards to reduced health checking. 
Checking behaviour as measured with the Y-BOCS showed reliable but not clinically 
significant change. This might have occurred with an extended intervention phase and/or 
emphasising and concentrating on the modules suspected as most relevant to checking 
behaviour (e.g., interoceptive exposure). A further consideration is whether the choice to 
conceptualise the primary presenting problem as health anxiety was the most appropriate. 
Given the patient’s comorbidity (i.e., with depression) and overlapping symptomology (i.e., 
checking is also a feature of OCD), it is reasonable to consider that a different clinician may 
have provided an alternative clinical formulation or treatment, and this may have been more 
effective.  
Critics could question whether the UP was delivered at all or in sufficient depth due to 
the limited number of sessions.  An issue with this study is also that therapist input occurred 
during the baseline phase.  The UP was not a focus in these early baseline sessions; however, 
the UP formulation was developed towards the end of the final assessment session. Receiving 
this formulation may have led to a level of improvement between the final assessment session 
and the first treatment session. Despite this, the visual trends of improvement within baseline 
periods (for three of the idiographic measures) were not statistically significant.  Other 
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methodological limitations were the lack of diagnostic certainty, lack of a genuine 
experimental design, lack of idiographic measures of health obsessions, mood or reassurance-
seeking, lack of any formal treatment adherence checks, lack of clinical competency checks, 
the lack of a nomothetic measure specific to health anxiety, lack of nomothetic 
generalisability measures and lack of any follow-up.   
These acknowledged limitations allow the following recommendations for future 
single-case investigations using the UP; (a) use of adherence, fidelity and competency 
checks, (b) ensuring spread of idiographic measures across anxiety and depression, (c) 
inclusion of control idiographic measures, (d) inclusion of generalisation nomothetic 
measures, (d) inclusion of a cross-over treatment comparison phase, or a withdrawal phase, 
(e) inclusions of a follow-up phase, (f) gathering of informant idiographic outcomes to assess 
changes in reassurance-seeking and (g) the employment of diagnostic procedures (e.g. 
Anxiety Disorder Interview Schedule; ADIS-IV-L; Di Nardo et al., 1994). 
In conclusion, this is the first empirical case study to investigate the effectiveness of 
abbreviated UP in treating health anxiety and comorbid depression in a working age adult. 
Encouraging results have been found for the relatively brief intervention used.  This research 
should act as a stimulus for therapists in routine practice to use the UP and evaluate outcomes 
using single case quasi-experimental and ethically appropriate true-experimental methods.  
This research showed improvements in behaviourally based idiographic measures and so 
exploring cognitive outcomes would be a useful next avenue.  As the UP acts on the shared 
mechanisms of depression and anxiety and because comorbidity is so frequent in Primary 
Care settings, then the UP appears a valuable tool for IAPT CBT therapists.  A pilot trial of 
the UP versus any single-disorder protocol is now indicated in IAPT settings and IAPT CBT 
therapists are also encouraged to produce genuine SCEDs of the UP.   
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Table 1: treatment content and UP adherence information  
Session 
(phase)  
UP module and content  Homework  
One 
(A) 















Module 1+2 (motivation enhancement + psychoeducation): 
Explanation of treatment rationale, education on the 
interactions between feelings, thoughts and behaviours, 







Module 3 (emotional awareness):                                  
Discussion of dominant emotions their functions, and how 




Six (B) Module 4 (cognitive reappraisal):                                   
Review of common thinking traps and their influence of 
emotions and behaviours.  
Evaluating 
automatic 
appraisals form  
Seven 
(B) 
Module 5 (emotionally driven behaviours [EDBs]):         
Review of maladaptive EDBs, identification of new ones 







Module 6 (awareness and tolerance of physical sensations): 
Explanation of the rationale for mindfulness-based strategies 






Module 7 (interoceptive + situational exposure):                 
Explanation of the habituation curve and utility of exposure, 






Module 8 (relapse prevention):                                        
Review of progress shown and summary of past sessions. 
NA 
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Measure  Baseline  Intervention  Nonoverlap indices  Difference 
  Mean SD τ  Mean SD τ  PEM PAND NAP  τ(A-B) 
Checking 
time 
 83.10 102.65 -.01  24.24 31.70 -0.31*  90% 81% 83%   0.67* 
Checking 
episodes 
 4.00 2.59 -.10  1.67 1.24 -0.11  88% 78% 79%   -0.59* 
Sleep 
duration 
 7.71 3.98 .03  9.24 2.09 -0.08  88% 64% 64%  .286 
Food intake  3.38 0.92 .07  3.62 0.79 0.32*  10% 49% 56%  .122 
*denotes significance at the p = <0.001 
Nonoverlap indices: PEM = percentage of data exceeding the median; PAND = percentage of all nonoverlapping data; NAP = nonoverlap of all pairs. 
τ indices: τ = Kendall’s tau; τ(A-B) =  Kendall’s Tau difference (baseline-intervention); τU =  Kendall’s τ(A-B) with adjustment for baseline trend. 
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Table 3. Nomothetic outcomes  





















CORE-10 241 201 12 7 
 









Y-BOCS 281 241 171 151  






Note. Change score 1 is the movement in scores from baseline-end to mid-therapy, change score 2 is the movement in scores from baseline to 
therapy end; reliable change threshold indicates the amount score change needed to meet reliable change,  clinical change threshold indicates the 
clinical cut-off for caseness. 1 indicates that the score represents clinical caseness at that point in time; * indicates reliable change has been 
met/exceeded. Norms obtained from Connell & Barkham, 2007 (UK norms); Frost, Steketee, Krause, & Trepanier, 1995 (US population norms); 
Deacon & Abramowitz, 2005 (US community norms)  
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Figure 1: Time series plots for idiographic measures. X-axis observations are equal to days. 
Baseline median   OLS trend line 
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